Digital health, diagnostics and medical devices, and the signals that matter for adoption, reimbursement and outcomes.
Page 2 of 8
Aug 6, 2026UnityPoint Health is implementing a suite of artificial intelligence (AI) solutions across its health system to streamline administrative tasks and help clinicians refocus on patient care. These measures range from real-time capacity tracking and ambient documentation to advanced AI-powered medical record review, reflecting a technology-first approach to combatting widespread burnout in healthcare.
Aug 4, 2026A persistent gap in telehealth adoption between rural and non-rural populations raises fresh questions about equitable digital health access. This new report illuminates the scale of the problem—and spotlights the challenges ahead for policymakers, providers, and technology innovators.
Jul 23, 2026Assured Health has raised $19 million for its AI agent platform, which promises to streamline and automate the provider credentialing and insurance onboarding process for health systems. The startup claims its technology can reduce timelines from months to days, potentially reshaping a major industry pain point.
Jul 21, 2026Nabla, a Paris-based AI-driven medical scribe company, has announced Brian Manning as its new CEO. The leadership change comes at a strategic moment as digital scribe vendors face mounting pressure to differentiate their technology and expand reach in the crowded clinical documentation market.
Jul 20, 2026A growing number of healthcare entities have raised concerns over a perceived decline in trust surrounding interoperability, the seamless exchange and use of health data across multiple systems and organizations. This in-depth analysis explores what a so-called 'trust recession' could mean for the industry's digital maturity, and outlines what entities should be watching for as the next chapter in healthcare data unfolds.
Jul 19, 2026As clinical algorithms proliferate in modern healthcare, concerns about validity and bias have also increased. MDCalc’s new system sets out to bring more transparency and rigor to the digital tools underpinning millions of daily medical decisions.
Jul 18, 2026The escalation of artificial intelligence and automated software in healthcare’s prior authorization and reimbursement processes is creating a heavily automated ‘arms race’ between payers and providers. Industry insiders now warn that this competitive automation increases administrative costs and may ultimately complicate patient care—unless genuine data interoperability and collaboration occur.
Jul 15, 2026Alzheimer’s diagnostics is on the cusp of transformation with innovative techniques providing broader access and richer clinical data. Improvements in testing methods may offer earlier detection and foster more informed treatment strategies as researchers chart new territory in dementia diagnostics.
Jul 13, 2026As healthcare grows ever more data-driven, the focus of cybersecurity moves from patient privacy to the protection of scientific innovation. This article examines the new threats facing biotech R&D, the vital importance of intellectual property, and how the broadening risk landscape is reshaping organizational strategies across the medical sector.
Jul 7, 2026While AI grabs headlines for clinical decision support, diagnostics, and patient-facing tools, healthcare’s massive and complex supply chain is an area ripe for data-driven improvement. Experts emphasize that automation, predictive analytics, and intelligent logistics could deliver major efficiency savings if AI is properly deployed—yet this potential remains barely explored compared to other applications.
Jul 7, 2026Penn Medicine has announced the rollout of K Health’s AI-driven intake solution for its virtual primary care program, representing a growing trend in healthcare’s digital transformation. This move is designed to free clinicians from time-intensive data collection tasks, potentially improving efficiency, patient experience, and allowing providers to spend more time on direct patient care. Yet, this transition prompts scrutiny around safety, accuracy, and the redefinition of patient-clinician interactions.
Jul 3, 2026With the FDA awarding breakthrough device designation to Aurenar’s V-Link, a novel ear-based nerve stimulation device, clinicians and patients may soon see a transformative approach to addressing the risks of brain hemorrhage. Results from early trials show a remarkable reduction in cerebral vasospasm, a major complication after a brain bleed, igniting discussions over the future of non-invasive neuroprotection.
Machine learning, predictive models and computational biology: how AI is changing discovery workflows and probability of success.
Drug development, clinical trials and industry dynamics. What changes timelines, risk and competitive positioning.
Gene therapy, CRISPR, synthetic biology and emerging platforms. Separating what is real from what is hype, and what actually translates.
Where capital is flowing and why the tape moves, across funding rounds, M&A, IPOs and market analysis.
FDA actions, approvals, policy shifts and compliance: how the rules change timelines and probability.